Natural inhibitors of thrombin

Thrombosis and Haemostasis

Volumn 111, Issue 4, 2014, Pages 583-589

  Huntington, James A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Exosite; Inhibition; Protease; Regulation; Structure

Indexed keywords

ANOPHELIN; ANTITHROMBIN; HAEMADIN; HEPARIN COFACTOR II; HIRUDIN; ORNITHODORIN; PLASMINOGEN ACTIVATOR INHIBITOR 3; PROTEASE NEXIN I; RHODNIIN; SERINE PROTEASE THROMBIN; SERINE PROTEINASE INHIBITOR; THROMBIN; THROMBIN INHIBITOR; TRIABIN; UNCLASSIFIED DRUG; VARIEGIN; INSECT PROTEIN;

ARTICLE; BLOOD CLOTTING; CRYSTAL STRUCTURE; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; SALIVA; THROMBOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CRYSTALLIZATION; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; ANTITHROMBIN PROTEINS; ANTITHROMBINS; BLOOD COAGULATION; CRYSTALLIZATION; HUMANS; INSECT PROTEINS; PROTEIN CONFORMATION; SERPINS; THROMBIN;

EID: 84897537641     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-10-0811     Document Type: Article

References (56)

1. Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood 2005; 106: 2605-2612.
2. Huntington J. Structural Insights into the Life History of Thrombin. In: Recent Advances in Thrombosis and Hemostasis 2008: Springer Japan, 2008, pp. 80-106.
3. Macfarlane RG. An Enzyme Cascade in the Blood Clotting Mechanism, and Its Function as a Biochemical Amplifier. Nature 1964; 202: 498-499.
4. Davie EW, Ratnoff OD. Waterfall Sequence for Intrinsic Blood Clotting. Science 1964; 145: 1310-1312.
5. Hoffman MM, Monroe DM. Rethinking the coagulation cascade. Curr Hematol Rep 2005; 4: 391-396.
6. Hoffman M, Monroe DM, 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-965.
7. Clemetson KJ. Platelets and primary haemostasis. Thromb Res 2012; 129: 220-224.
8. Krishnaswamy S, Mann KG, Nesheim ME. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J Biol Chem 1986; 261: 8977-8984.
9. Davie EW, Kulman JD. An overview of the structure and function of thrombin. Semin Thromb Hemost 2006; 32 (Suppl 1): 3-15.
10. Bode W, Turk D, Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1992; 1: 426-471.
11. Fuentes-Prior P, Iwanaga Y, Huber R, et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 2000; 404: 518-525.
12. Pechik I, Madrazo J, Mosesson MW, et al. Crystal structure of the complex between thrombin and the central "E" region of fibrin. Proc Natl Acad Sci USA 2004; 101: 2718-2723.
13. Gandhi PS, Chen Z, Di Cera E. Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1. J Biol Chem 2010; 285: 15393-15398.
14. Myles T, Yun TH, Hall SW, et al. An extensive interaction interface between thrombin and factor V is required for factor V activation. J Biol Chem 2001; 276: 25143-25149.
15. Myles T, Yun TH, Leung LL. Structural requirements for the activation of human factor VIII by thrombin. Blood 2002; 100: 2820-2826.
16. Bukys MA, Orban T, Kim PY, et al. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII. J Biol Chem 2006; 281: 18569-18580.
17. Hall SW, Nagashima M, Zhao L, et al. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. J Biol Chem 1999; 274: 25510-25516.
18. Janus TJ, Lewis SD, Lorand L, et al. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry 1983; 22: 6269-6272.
19. De Cristofaro R, De Candia E, Landolfi R, et al. Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. Biochemistry 2001; 40: 13268-13273.
20. Celikel R, McClintock RA, Roberts JR, et al. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science 2003; 301: 218-221.
21. Dumas JJ, Kumar R, Seehra J, et al. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science 2003; 301: 222-226.
22. Nogami K, Zhou Q, Myles T, et al. Exosite-interactive regions in the A1 and A2 domains of factor VIII facilitate thrombin-catalyzed cleavage of heavy chain. J Biol Chem 2005; 280: 18476-18487.
23. Segers K, Dahlback B, Bock PE, et al. The role of thrombin exosites I and II in the activation of human coagulation factor V. J Biol Chem 2007; 282: 33915-33924.
24. Koh CY, Kini RM. Molecular diversity of anticoagulants from haematophagous animals. Thromb Haemost 2009; 102: 437-453.
25. Francischetti IM. Platelet aggregation inhibitors from hematophagous animals. Toxicon 2010; 56: 1130-1144.
26. Dodt J, Otte M, Strube KH, et al. Thrombin inhibitors of bloodsucking animals. Semin Thromb Hemost 1996; 22: 203-208.
27. Bode W, Huber R. Structural basis of the endoproteinase-protein inhibitor interaction. Biochim Biophys Acta 2000; 1477: 241-252.
28. Corral-Rodriguez MA, Macedo-Ribeiro S, Pereira PJ, et al. Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications. J Med Chem 2010; 53: 3847-3861.
29. Rydel TJ, Ravichandran KG, Tulinsky A, et al. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 1990; 249: 277-280.
30. Rydel TJ, Tulinsky A, Bode W, et al. Refined structure of the hirudin-thrombin complex. J Mol Biol 1991; 221: 583-601.
31. Grutter MG, Priestle JP, Rahuel J, et al. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J 1990; 9: 2361-2365.
32. van de Locht A, Lamba D, Bauer M, et al. Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J 1995; 14: 5149-5157.
33. van de Locht A, Stubbs MT, Bode W, et al. The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J 1996; 15: 6011-6017.
34. Ruhlmann A, Kukla D, Schwager P, et al. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. J Mol Biol 1973; 77: 417-436.
35. Fuentes-Prior P, Noeske-Jungblut C, Donner P, et al. Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci USA 1997; 94: 11845-11850.
36. Noeske-Jungblut C, Haendler B, Donner P, et al. Triabin, a highly potent exosite inhibitor of thrombin. J Biol Chem 1995; 270: 28629-28634.
37. Richardson JL, Kroger B, Hoeffken W, et al. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J 2000; 19: 5650-5660.
38. Martin PD, Malkowski MG, Box J, et al. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK. Structure 1997; 5: 1681-1693.
39. Richardson JL, Fuentes-Prior P, Sadler JE, et al. Characterization of the residues involved in the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. Biochemistry 2002; 41: 2535-2542.
40. Koh CY, Kazimirova M, Trimnell A, et al. Variegin, a novel fast and tight binding thrombin inhibitor from the tropical bont tick. J Biol Chem 2007; 282: 29101-29113.
41. Koh CY, Kumar S, Kazimirova M, et al. Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors. PloS one 2011; 6: e26367.
42. Figueiredo AC, de Sanctis D, Gutierrez-Gallego R, et al. Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector. Proc Natl Acad Sci USA 2012; 109: E3649-3658.
43. Huntington JA. Thrombin inhibition by the serpins. J Thromb Haemost 2013; 11 (Suppl 1): 254-264.
44. Rau JC, Beaulieu LM, Huntington JA, et al. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007; 5 (Suppl 1): 102-115.
45. Gettins PG. Serpin structure, mechanism, and function. Chem Rev 2002; 102: 4751-4804.
46. Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000; 407: 923-926.
47. Li W, Johnson DJ, Esmon CT, et al. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 2004; 11: 857-862.
48. Baglin TP, Carrell RW, Church FC, et al. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc Natl Acad Sci USA 2002; 99: 11079-11084.
49. Li W, Adams TE, Nangalia J, et al. Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. Proc Natl Acad Sci USA 2008; 105: 4661-4666.
50. Li W, Huntington JA. Crystal structures of protease nexin-1 in complex with heparin and thrombin suggest a 2-step recognition mechanism. Blood 2012; 120: 459-467.
51. Zhou A, Carrell RW, Huntington JA. The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop. J Biol Chem 2001; 276: 27541-27547.
52. Fredenburgh JC, Stafford AR, Weitz JI. Conformational changes in thrombin when complexed by serpins. J Biol Chem 2001; 276: 44828-44834.
53. Bock PE, Olson ST, Bjork I. Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I. J Biol Chem 1997; 272: 19837-19845.
54. Li W, Johnson DJ, Adams TE, et al. Thrombin inhibition by serpins disrupts exosite II. J Biol Chem 2010; 285: 38621-38629.
55. Wells MJ, Sheffield WP, Blajchman MA. The clearance of thrombin-antithrombin and related serpin-enzyme complexes from the circulation: role of various hepatocyte receptors. Thromb Haemost 1999; 81: 325-337.
56. Carter WJ, Cama E, Huntington JA. Crystal structure of thrombin bound to heparin. J Biol Chem 2005; 280: 2745-2749.